書(shū)目名稱 | Lung Cancer |
副標(biāo)題 | New Understandings a |
編輯 | Anne C. Chiang,Roy S. Herbst |
視頻video | http://file.papertrans.cn/590/589072/589072.mp4 |
概述 | Highlight recent updates in lung cancer management, both NSCLC and SCLC..Focus on translational approaches in understanding resistance biology to inform clinical management in patients treated with im |
叢書(shū)名稱 | Current Cancer Research |
圖書(shū)封面 |  |
描述 | .Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach.? For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment.? Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.. |
出版日期 | Book 2021 |
關(guān)鍵詞 | lung cancer; NSCLC; SCLC; lung cancer immunotherapy; tumor microenvironment; tumor macroenvironment; lung |
版次 | 1 |
doi | https://doi.org/10.1007/978-3-030-74028-3 |
isbn_softcover | 978-3-030-74030-6 |
isbn_ebook | 978-3-030-74028-3Series ISSN 2199-2584 Series E-ISSN 2199-2592 |
issn_series | 2199-2584 |
copyright | Springer Nature Switzerland AG 2021 |